{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:23:21Z","timestamp":1788899001453,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11033-020-05938-x","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T17:02:51Z","timestamp":1603731771000},"page":"8859-8866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5816-775X","authenticated-orcid":false,"given":"Mehdi","family":"Hedayati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziyeh","family":"Abooshahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Adeleh","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Salehipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Ahmadikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seti","family":"Boroomand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"issue":"7","key":"5938_CR1","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/1055-9965.EPI-13-0242","volume":"22","author":"B Aschebrook-Kilfoy","year":"2013","unstructured":"Aschebrook-Kilfoy B, Schechter RB, Shih Y-CT, Kaplan EL, Chiu BC-H, Angelos P, Grogan RH (2013) The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Prev Biomark 22(7):1252\u20131259","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"1","key":"5938_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"SA Razavi","year":"2019","unstructured":"Razavi SA, Afsharpad M, Modarressi MH, Zarkesh M, Yaghmaei P, Nasiri S, Tavangar SM, Gholami H, Daneshafrooz A, Hedayati M (2019) Validation of reference genes for normalization of relative qRt-pcR studies in papillary thyroid carcinoma. Sci Rep 9(1):1\u201311","journal-title":"Sci Rep"},{"issue":"S2","key":"5938_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/modpathol.2010.129","volume":"24","author":"VA LiVolsi","year":"2011","unstructured":"LiVolsi VA (2011) Papillary thyroid carcinoma: an update. Mod Pathol 24(S2):S1","journal-title":"Mod Pathol"},{"key":"5938_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fcell.2020.00385","volume":"8","author":"R Abooshahab","year":"2020","unstructured":"Abooshahab R, Hooshmand K, Razavi SA, Gholami M, Sanoie M, Hedayati M (2020) Plasma metabolic profiling of human thyroid nodules by gas chromatography-mass spectrometry (GC-MS)-based untargeted metabolomics. Front Cell Dev Biol 8:385","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"5938_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/dc.20830","volume":"36","author":"ZW Baloch","year":"2008","unstructured":"Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36(6):425\u2013437","journal-title":"Diagn Cytopathol"},{"issue":"11","key":"5938_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1089\/thy.2009.0274","volume":"19","author":"ES Cibas","year":"2009","unstructured":"Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Thyroid 19(11):1159\u20131165","journal-title":"Thyroid"},{"issue":"4","key":"5938_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000339959","volume":"56","author":"M Bongiovanni","year":"2012","unstructured":"Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW (2012) The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 56(4):333\u2013339","journal-title":"Acta Cytol"},{"issue":"2","key":"5938_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1590\/S0004-27302013000200001","volume":"57","author":"LS Ward","year":"2013","unstructured":"Ward LS, Kloos RT (2013) Molecular markers in the diagnosis of thyroid nodules. Arquivos Brasileiros de Endocrinologia Metabologia 57(2):89\u201397","journal-title":"Arquivos Brasileiros de Endocrinologia Metabologia"},{"issue":"2","key":"5938_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/thy.2013.0278","volume":"24","author":"M Eszlinger","year":"2014","unstructured":"Eszlinger M, Krogdahl A, M\u00fcnz S, Rehfeld C, Precht Jensen EM, Ferraz C, B\u00f6senberg E, Drieschner N, Scholz M, Heged\u00fcs L (2014) Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid 24(2):305\u2013313","journal-title":"Thyroid"},{"key":"5938_CR10","doi-asserted-by":"crossref","unstructured":"Abooshahab R, Gholami M, Sanoie M, Azizi F, Hedayati M (2019) Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation. Endocrine 1\u201314","DOI":"10.1007\/s12020-019-01904-1"},{"issue":"3","key":"5938_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12020-017-1368-4","volume":"57","author":"SA Razavi","year":"2017","unstructured":"Razavi SA, Modarressi MH, Yaghmaei P, Tavangar SM, Hedayati M (2017) Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? Endocrine 57(3):428\u2013435","journal-title":"Endocrine"},{"issue":"4","key":"5938_CR12","doi-asserted-by":"publisher","first-page":"M111","DOI":"10.1074\/mcp.M111.014647","volume":"11","author":"A Naba","year":"2012","unstructured":"Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO (2012) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 11(4):M111","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"5938_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrm1130","volume":"4","author":"R Timpl","year":"2003","unstructured":"Timpl R, Sasaki T, Kostka G, Chu M-L (2003) Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4(6):479","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5938_CR14","doi-asserted-by":"crossref","unstructured":"Cangemi C, Hansen ML, Argraves WS, Rasmussen LM (2014) Fibulins and their role in cardiovascular biology and disease. In: Advances in clinical chemistry, vol\u00a067. Elsevier, pp\u00a0245\u2013265","DOI":"10.1016\/bs.acc.2014.09.008"},{"issue":"4","key":"5938_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0092-8674(89)90097-4","volume":"58","author":"WS Argraves","year":"1989","unstructured":"Argraves WS, Dickerson K, Burgess WH, Ruoslahti E (1989) Fibulin, a novel protein that interacts with the fibronectin receptor \u03b2 subunit cytoplasmic domain. Cell 58(4):623\u2013629","journal-title":"Cell"},{"issue":"2","key":"5938_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ydbio.2008.04.029","volume":"319","author":"MA Cooley","year":"2008","unstructured":"Cooley MA, Kern CB, Fresco VM, Wessels A, Thompson RP, McQuinn TC, Twal WO, Mjaatvedt CH, Drake CJ, Argraves WS (2008) Fibulin-1 is required for morphogenesis of neural crest-derived structures. Dev Biol 319(2):336\u2013345","journal-title":"Dev Biol"},{"issue":"4","key":"5938_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/43.4.7534784","volume":"43","author":"EF Roark","year":"1995","unstructured":"Roark EF, Keene DR, Haudenschild CC, Godyna S, Little CD, Argraves WS (1995) The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem 43(4):401\u2013411","journal-title":"J Histochem Cytochem"},{"issue":"8","key":"5938_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/mc.20735","volume":"50","author":"M Kanda","year":"2011","unstructured":"Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, Fujii T, Nishikawa Y, Sugimoto H, Takeda S, Nakao A (2011) Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinogen 50(8):571\u2013579","journal-title":"Mol Carcinogen"},{"issue":"12","key":"5938_CR19","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/sj.bjc.6604760","volume":"99","author":"Y Cheng","year":"2008","unstructured":"Cheng Y, Jin H, Liu X, Siu J, Wong Y, Ng E, Yu J, Leung W, Sung J, Chan F (2008) Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J Cancer 99(12):2083\u20132087","journal-title":"Br J Cancer"},{"issue":"4","key":"5938_CR20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<654::AID-IJC26>3.0.CO;2-7","volume":"75","author":"Y Hayashido","year":"1998","unstructured":"Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS, Rochefort H (1998) Estradiol and fibulin-1 inhibit motility of human ovarian\u2010and breast\u2010cancer cells induced by fibronectin. Int J Cancer 75(4):654\u2013658","journal-title":"Int J Cancer"},{"issue":"7","key":"5938_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1205171","volume":"21","author":"F Moll","year":"2002","unstructured":"Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, Giacalone P-L, Chalbos D, Maudelonde T, Rochefort H, Pujol P (2002) Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 21(7):1097","journal-title":"Oncogene"},{"issue":"6","key":"5938_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.bjc.6600802","volume":"88","author":"L Greene","year":"2003","unstructured":"Greene L, Twal W, Duffy M, McDermott E, Hill A, O\u2019Higgins N, McCann A, Dervan P, Argraves W, Gallagher W (2003) Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer 88(6):871","journal-title":"Br J Cancer"},{"issue":"2","key":"5938_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/1541-7786.MCR-08-0132","volume":"7","author":"H Seeliger","year":"2009","unstructured":"Seeliger H, Camaj P, Ischenko I, Kleespies A, De Toni EN, Thieme SE, Blum H, Assmann G, Jauch K-W, Bruns CJ (2009) EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol Cancer Res 7(2):189\u2013198","journal-title":"Mol Cancer Res"},{"issue":"6","key":"5938_CR24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471\u20131474","journal-title":"Ann Surg Oncol"},{"issue":"8\u20139","key":"5938_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0945-053X(98)90114-7","volume":"17","author":"JL Barth","year":"1998","unstructured":"Barth JL, Argraves KM, Roark EF, Little CD, Argraves WS (1998) Identification of chicken and C. elegans fibulin-1 homologs and characterization of the C. elegans fibulin-1 gene. Matrix Biol 17(8\u20139):635\u2013646","journal-title":"Matrix Biol"},{"issue":"4","key":"5938_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1091\/mbc.e08-06-0621","volume":"20","author":"SA Williams","year":"2009","unstructured":"Williams SA, Schwarzbauer JE (2009) A shared mechanism of adhesion modulation for tenascin-C and fibulin-1. Mol Biol Cell 20(4):1141\u20131149","journal-title":"Mol Biol Cell"},{"issue":"16","key":"5938_CR27","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/pros.20667","volume":"67","author":"A Wlazlinski","year":"2007","unstructured":"Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, M\u00fcller M, Schulz WA (2007) Downregulation of several fibulin genes in prostate cancer. Prostate 67(16):1770\u20131780","journal-title":"Prostate"},{"issue":"1","key":"5938_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.juro.2013.01.098","volume":"190","author":"W Xiao","year":"2013","unstructured":"Xiao W, Wang J, Li H, Guan W, Xia D, Yu G, Xiao H, Lang B, Ma X, Liu J (2013) Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression. J Urol 190(1):291\u2013301","journal-title":"J Urol"},{"issue":"1","key":"5938_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/1471-2407-14-677","volume":"14","author":"W Xiao","year":"2014","unstructured":"Xiao W, Wang J, Li H, Xia D, Yu G, Yao W, Yang Y, Xiao H, Lang B, Ma X (2014) Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence. BMC Cancer 14(1):677","journal-title":"BMC Cancer"},{"issue":"8","key":"5938_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/onc.2014.52","volume":"34","author":"Q Wang","year":"2015","unstructured":"Wang Q, Shen B, Chen L, Zheng P, Feng H, Hao Q, Liu X, Liu L, Xu S, Chen J (2015) Extracellular calumenin suppresses ERK1\/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis. Oncogene 34(8):1006","journal-title":"Oncogene"},{"issue":"2","key":"5938_CR31","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/en.2004-1239","volume":"146","author":"A Bardin","year":"2005","unstructured":"Bardin A, Moll F, Margueron R, Delfour C, Chu M, Maudelonde T, Cavailles V, Pujol P (2005) Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. Endocrinology 146(2):760\u2013768","journal-title":"Endocrinology"},{"issue":"19","key":"5938_CR32","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1242\/dev.02007","volume":"132","author":"JM Muriel","year":"2005","unstructured":"Muriel JM, Dong C, Hutter H, Vogel BE (2005) Fibulin-1C and Fibulin-1D splice variants have distinct functions and assemble in a hemicentin-dependent manner. Development 132(19):4223\u20134234","journal-title":"Development"},{"key":"5938_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cca.2018.04.038","volume":"483","author":"MM Watany","year":"2018","unstructured":"Watany MM, Elmashad NM, Badawi R, Hawash N (2018) Serum FBLN1 and STK31 as biomarkers of colorectal cancer and their ability to noninvasively differentiate colorectal cancer from benign polyps. Clin Chim Acta 483:151\u2013155","journal-title":"Clin Chim Acta"},{"issue":"9","key":"5938_CR34","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jjco\/hyv094","volume":"45","author":"Y Cui","year":"2015","unstructured":"Cui Y, Liu J, Yin H-B, Liu Y-F, Liu J-H (2015) Fibulin-1 functions as a prognostic factor in lung adenocarcinoma. Jpn J Clin Oncol 45(9):854\u2013859","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"5938_CR35","first-page":"339","volume":"7","author":"J Zhu","year":"2015","unstructured":"Zhu J, Chen R, Mo L, Tang H, Kuang Y, Fei W, He C, Hu X (2015) Expression of fibulin-1 predicted good prognosis in patients with colorectal cancer. Am J Transl Res 7(2):339","journal-title":"Am J Transl Res"},{"issue":"7","key":"5938_CR36","doi-asserted-by":"publisher","first-page":"9399","DOI":"10.1007\/s13277-015-4537-1","volume":"37","author":"L Feng","year":"2016","unstructured":"Feng L, Yao C, Li P, Feng Y, Wang F, Liu Y-F, Guo Y-B, Mao Q-S, Xue W-J (2016) Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer. Tumor Biol 37(7):9399\u20139410","journal-title":"Tumor Biol"},{"issue":"7","key":"5938_CR37","first-page":"505","volume":"10","author":"M Jost","year":"2000","unstructured":"Jost M, Kari C, Rodeck U (2000) The EGF receptor\u2014an&nbsp;essential regulator of multiple epidermal functions. Eur J Dermatol 10(7):505\u2013510","journal-title":"Eur J Dermatol"},{"issue":"2","key":"5938_CR38","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ijrobp.2003.11.041","volume":"59","author":"RS Herbst","year":"2004","unstructured":"Herbst RS (2004) Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59(2):S21\u2013S26","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5938_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fcell.2020.00522","volume":"8","author":"K Harikrishnan","year":"2020","unstructured":"Harikrishnan K, Joshi O, Madangirikar S, Balasubramanian N (2020) Cell derived matrix fibulin-1 associates with epidermal growth factor receptor to inhibit its activation, localization and function in lung cancer calu-1 cells. Front Cell Dev Biol 8:522","journal-title":"Front Cell Dev Biol"},{"key":"5938_CR40","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fcell.2020.00478","volume":"8","author":"J Gong","year":"2020","unstructured":"Gong J, Jie Y, Xiao C, Zhou W, Li X, Chen Y, Wu Y, Cao J, Zhang Q, Gao Z (2020) Increased expression of fibulin-1 is associated with hepatocellular carcinoma progression by regulating the notch signaling pathway. Front Cell Dev Biol 8:478","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"5938_CR41","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3892\/or.2013.2309","volume":"29","author":"S Zhang","year":"2013","unstructured":"Zhang S, Feng X-L, Shi L, Gong C-J, He Z-J, Wu H-J, Ling T-Y (2013) Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma. Oncol Rep 29(5):1819\u20131826","journal-title":"Oncol Rep"},{"issue":"1","key":"5938_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13277-013-1015-5","volume":"35","author":"B-J Wu","year":"2014","unstructured":"Wu B-J, Zhou Z-P, Li W-P, Ding W, Wu Y-Z, Zhou Z-W, Zhang R-Q, Liu Q-F, Jiang H (2014) Abnormal hypermethylation and clinicopathological significance of FBLN1 gene in cutaneous melanoma. Tumor Biol 35(1):123\u2013127","journal-title":"Tumor Biol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05938-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05938-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05938-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T01:32:18Z","timestamp":1635211938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05938-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5938"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05938-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}